American Century Companies’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.7B Sell
1,845,922
-16,031
-0.9% -$16.3M 0.87% 14
2025
Q4
$2B Sell
1,861,953
-99,692
-5% -$95.3M 1.01% 12
2025
Q3
$1.5B Buy
1,961,645
+120,905
+7% +$90M 0.76% 14
2025
Q2
$1.43B Sell
1,840,740
-134,128
-7% -$104M 0.78% 13
2025
Q1
$1.63B Sell
1,974,868
-330,070
-14% -$275M 1% 10
2024
Q4
$1.78B Buy
2,304,938
+41,195
+2% +$34.1M 1.02% 10
2024
Q3
$2.01B Buy
2,263,743
+193,862
+9% +$174M 1.17% 9
2024
Q2
$1.87B Buy
2,069,881
+100,426
+5% +$80.3M 1.15% 9
2024
Q1
$1.53B Sell
1,969,455
-7,084
-0.4% -$5.04M 0.96% 10
2023
Q4
$1.15B Buy
1,976,539
+48,585
+3% +$28.4M 0.79% 12
2023
Q3
$1.04B Buy
1,927,954
+297,672
+18% +$153M 0.8% 12
2023
Q2
$765M Buy
1,630,282
+115,440
+8% +$48.4M 0.58% 17
2023
Q1
$520M Buy
1,514,842
+340,159
+29% +$115M 0.41% 37
2022
Q4
$430M Buy
1,174,683
+576,450
+96% +$204M 0.35% 53
2022
Q3
$193M Buy
598,233
+105,686
+21% +$33.5M 0.17% 146
2022
Q2
$160M Buy
492,547
+448,772
+1,025% +$135M 0.13% 180
2022
Q1
$12.5M Sell
43,775
-3,069
-7% -$790K 0.01% 835
2021
Q4
$12.9M Buy
46,844
+16,351
+54% +$4.15M 0.01% 813
2021
Q3
$7.05M Sell
30,493
-64,660
-68% -$16M ﹤0.01% 935
2021
Q2
$21.8M Buy
95,153
+54,151
+132% +$10.9M 0.01% 650
2021
Q1
$7.66M Buy
41,002
+4,646
+13% +$909K 0.01% 834
2020
Q4
$6.14M Sell
36,356
-64,318
-64% -$9.6M ﹤0.01% 851
2020
Q3
$14.9M Buy
100,674
+43,290
+75% +$6.7M 0.01% 615
2020
Q2
$9.42M Buy
57,384
+10,610
+23% +$1.63M 0.01% 684
2020
Q1
$6.49M Buy
46,774
+5,038
+12% +$692K 0.01% 683
2019
Q4
$5.49M Sell
41,736
-246,569
-86% -$28.6M 0.01% 796
2019
Q3
$32.2M Sell
288,305
-182,004
-39% -$20.3M 0.03% 404
2019
Q2
$52.1M Buy
470,309
+107,268
+30% +$12.6M 0.05% 360
2019
Q1
$47.1M Sell
363,041
-36,394
-9% -$4.43M 0.05% 365
2018
Q4
$46.2M Buy
399,435
+6,248
+2% +$698K 0.05% 350
2018
Q3
$42.2M Sell
393,187
-49,084
-11% -$4.91M 0.04% 378
2018
Q2
$37.7M Sell
442,271
-981,464
-69% -$80.6M 0.04% 399
2018
Q1
$110M Sell
1,423,735
-103,774
-7% -$8.35M 0.11% 247
2017
Q4
$129M Sell
1,527,509
-715,357
-32% -$60.9M 0.13% 221
2017
Q3
$192M Buy
2,242,866
+381,299
+20% +$31.3M 0.19% 161
2017
Q2
$153M Sell
1,861,567
-893,252
-32% -$72.9M 0.16% 192
2017
Q1
$232M Buy
2,754,819
+424,763
+18% +$34M 0.24% 123
2016
Q4
$171M Buy
2,330,056
+1,387,386
+147% +$103M 0.18% 168
2016
Q3
$75.7M Buy
942,670
+198,494
+27% +$15.9M 0.08% 296
2016
Q2
$58.6M Sell
744,176
-130,210
-15% -$9.8M 0.07% 333
2016
Q1
$63M Buy
874,386
+554,386
+173% +$41.9M 0.07% 322
2015
Q4
$27M Buy
320,000
+286,853
+865% +$23.8M 0.03% 468
2015
Q3
$2.77M Sell
33,147
-1,031,030
-97% -$87M ﹤0.01% 976
2015
Q2
$88.8M Sell
1,064,177
-338,961
-24% -$25.8M 0.1% 275
2015
Q1
$102M Sell
1,403,138
-507,107
-27% -$36.1M 0.11% 247
2014
Q4
$132M Buy
1,910,245
+439,017
+30% +$29.6M 0.15% 195
2014
Q3
$95.4M Sell
1,471,228
-1,719,038
-54% -$109M 0.11% 240
2014
Q2
$198M Sell
3,190,266
-494,892
-13% -$29.5M 0.23% 122
2014
Q1
$217M Sell
3,685,158
-61,486
-2% -$3.43M 0.26% 112
2013
Q4
$191M Sell
3,746,644
-692,790
-16% -$34.7M 0.23% 126
2013
Q3
$223M Buy
4,439,434
+311,107
+8% +$16.3M 0.28% 96
2013
Q2
$203M Buy
+4,128,327
New +$225M 0.27% 100

Other funds holding LLY

American Century Companies's LLY Position: Q1 2026 in Review

American Century Companies reduced its Eli Lilly (LLY) stake by 0.86% in Q1 2026, selling an estimated $16.3M and leaving 1,845,922 shares worth $1.7B. The position accounts for 0.87% of the portfolio, ranked #14.

American Century Companies first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.01B in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • American Century Companies held 1,845,922 shares of Eli Lilly worth $1.7B as of Q1 2026.
  • American Century Companies sold 16,031 Eli Lilly shares in Q1 2026, an estimated $16.3M.
  • Eli Lilly made up 0.87% of American Century Companies's portfolio in Q1 2026, its #14 holding.
  • American Century Companies first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • American Century Companies's Eli Lilly position peaked at $2.01B in Q3 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.